Development asset linked to Eye & ENT in public FDA and regional records.
pharma · Vestibular Disorder
Eye & ENT
Eye & ENT Hospital of Fudan University
Eye & ENT drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Eye & ENT pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Eye & ENT drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.